Ocular Penetration of Topical Tacrolimus Eye Drops

• Status: Unknown status
• Trial end date: 2016-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Investigators aim to evaluate the ocular penetration of topical tacrolimus 0.03% eye drops.

Topical tacrolimus 0.03% will be instilled into the eyes of patients 15 minutes before cataract surgery. Aqueous samples will be collected at the time of cataract surgery and will be subjected to detection of presence and level of tacrolimus.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Eye Center and The Eye Foundation for Research in Ophthalmology
• Treatments: Tacrolimus

Criteria

Inclusion Criteria:

• Any age or gender

• Patients scheduled for routine cataract surgery

• Clear healthy cornea

Exclusion Criteria:

• Corneal pathology

• Ocular surface disease

• Intraocular inflammation